SCHEMBL5319944

SCHEMBL5319944

CCC(N)(C(=O)O)C(C)N

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ARG1 P05089 3/20 0.40
ARG2 P78540 2/20 0.40
MEN1 O00255 2/20 0.39
CYP1A2 P05177 2/20 0.39
KMT2A Q03164 2/20 0.39
ALDH1A1 P00352 1/20 0.39
THRB P10828 1/20 0.39
ODC1 P11926 1/20 0.36
KDM4E B2RXH2 1/20 0.35
LMNA P02545 1/20 0.35
MAPT P10636 1/20 0.35
RAB9A P51151 1/20 0.35
BLM P54132 1/20 0.35
PMP22 Q01453 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
NOS3 P29474 1/20 0.35
NOS1 P29475 1/20 0.35
NOS2 P35228 1/20 0.35
GABRP O00591 2/20 0.34
GABRD O14764 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2129918 0.83 ARG1 (0.50) ARG1ARG2MEN1CYP1A2KMT2A
SCHEMBL16116350 0.83 ARG1 (0.50) ARG1ARG2MEN1CYP1A2KMT2A
SCHEMBL8768541 0.81 ARG1 (0.40) ARG1ARG2CYP1A2ODC1KDM4E
SCHEMBL28577951 0.81 ARG1 (0.40) ARG1ARG2MEN1CYP1A2KMT2A
Hydrochloric Acid SCHEMBL27976606 0.81 ARG1 (0.48) ARG1ARG2MEN1CYP1A2KMT2A
SCHEMBL2156784 0.77 ODC1 (0.47) ARG1ARG2MEN1CYP1A2KMT2A
SCHEMBL638315 0.76 ARG1 (0.37) ARG1ARG2ODC1KDM4ELMNA
SCHEMBL2147212 0.76 ARG1 (0.49) ARG1ARG2ODC1KDM4ELMNA
SCHEMBL7653149 0.74 SMN1; SMN2 (0.56) ARG1ARG2CYP1A2BLMSMN1; SMN2
SCHEMBL21802412 0.74 ODC1 (0.63) ARG1ARG2CYP1A2KMT2ATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070258899-A1 Diagnostic and therapeutic agents KARYON-CTT LTD (FI) 2007-11-08 US disclosed
WO-2007113385-A1 DIAGNOSTIC AND THERAPEUTIC AGENTS KARYON-CTT LTD (FI) 2007-10-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070258899-A1 Diagnostic and therapeutic agents YBX1, MLX, TPX2 ARG1 989/4885ARG2 846/4885MEN1 927/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.